FDA Committee Recommends 2022–2023 Influenza Vaccine Strains

The Vaccines and Related Biological Products Advisory Committee voted to change two influenza vaccine strains for the 2022–2023 season, after low vaccine effectiveness this season.
Medscape Medical News